Загрузка...
Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders with a global burden of approximately 6.1 million patients. Alpha-synuclein has been linked to both the sporadic and familial forms of the disease. Moreover, alpha-synuclein is present in Lewy-bodies, the neuropathologica...
Сохранить в:
| Опубликовано в: : | Front Mol Neurosci |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6906193/ https://ncbi.nlm.nih.gov/pubmed/31866823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnmol.2019.00299 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|